• Episode 216: Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma

  • Sep 3 2024
  • Length: 36 mins
  • Podcast

Episode 216: Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma

  • Summary

  • Joe Selvaggi talks with Pioneer Institute Director Bill Smith about the Inflation Reduction Act's impact on drug pricing negotiations and its potential effects on drug development, consumers, and taxpayers.
    Show more Show less
activate_WEBCRO358_DT_T2

What listeners say about Episode 216: Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.